Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin in Prediabetes or Early Diabetes
NCT02754739Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pravastatin in prediabetes and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Samsung Medical Center. Primary endpoint: Homeostatic Model Assessment Index for Insulin Resistance at 24 weeks. Started Apr 2014; status: completed.
02
Drugs
pravastatin
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02754739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02754739.